NCT01772914已完成不适用
Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test
University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年2月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid
研究概览
简要总结
The purpose of this study is to determine whether copeptin levels are affected by food intake.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Aged over 18 years
排除标准
- •Intake of any kind of medication (except birth control pill)
- •BMI >30 kg/m2
- •Evidence of any acute illness
- •History of chronic illness
- •Pregnancy
- •Known galactosemia or maltose malabsorption
- •Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l
结局指标
主要结局
Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid
时间窗: 30, 60, 90, 120, 180 minutes after intake of the test liquids
次要结局
未报告次要终点
研究者
Mirjam Christ-Crain
Prof. Dr. med.
University Hospital, Basel, Switzerland
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study of Copeptin as a Diagnostic Marker for Acute PancreatitisAcute PancreatitisPancreatitisNCT01293318University Hospital, Basel, Switzerland150
已完成
1 期
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance TestMetabolic DiseasesNCT04958109Massachusetts General Hospital16
已完成
1 期
A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent FormulationOsteoporosis, PostmenopausalBone DiseasesOsteoporosisNCT00965978Astellas Pharma Inc48
已完成
不适用
Glycemic Response TestingGlycemic ResponseNCT02020798PepsiCo Global R&D38
已完成
不适用
Using Continuous Glucose Monitoring to Understand the Glycemic Impact of FoodCurrently Taking MetforminType 2 DiabetesNCT00818077HealthPartners Institute15